Phase II Study of Carboplatin Plus Docetaxel (Taxotere) in Patients With Anaplastic Prostate Carcinoma.

Trial Profile

Phase II Study of Carboplatin Plus Docetaxel (Taxotere) in Patients With Anaplastic Prostate Carcinoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Jan 2014

At a glance

  • Drugs Carboplatin (Primary) ; Docetaxel (Primary) ; Cisplatin; Etoposide
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Nov 2012 Planned End Date changed from 1 May 2013 to 1 May 2014 as reported by ClinicalTrials.gov.
    • 11 Nov 2011 Planned End Date changed from 1 May 2012 to 1 May 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top